Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia

Clinical trial NCT04901676 · SUSPENDED

Trial details

NCT number: NCT04901676
Sponsor: Hospital Israelita Albert Einstein
Status: SUSPENDED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Pneumonia

Start date: 2021-09-09
Primary completion: 2023-01-01
Enrollment: 612

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.